Hutchmed begins phase-three trials of lymphoma therapy in China
23rd Mar 2026 10:21
(Alliance News) - Hutchmed China Ltd on Monday said it had begun phase-three clinical trials of its lymphoma treatment in China. Read More
| Price | 216.00p on 22-04-2026 at 07:22:27 |
|---|---|
| Change | -4.50p -2.04% |
| Buy | 216.00p |
| Sell | 213.00p |
| Last Trade: | Buy 1.00 at 216.00p |
| Day's Volume: | 8,727 |
| Last Close: | 220.50p |
| Open: | 216.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 215.00p - 216.00p |
| 52wk Range: | 192.00p - 292.00p |
| Market Capitalisation: | £1.86b |
| VWAP: | 214.95623p |
| Shares in Issue: | 859.74m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1 | 216.00p | SI Trade |
08:22:26 - 22-Apr-26 |
| Buy* | 4,000 | 214.498p | Ordinary |
08:14:40 - 22-Apr-26 |
| Buy* | 750 | 214.50p | Ordinary |
08:04:35 - 22-Apr-26 |
| Buy* | 1 | 215.00p | SI Trade |
08:03:52 - 22-Apr-26 |
| Sell* | 1 | 217.07p | Ordinary |
15:55:19 - 21-Apr-26 |
| Buy* | 1 | 220.85p | Ordinary |
15:14:01 - 21-Apr-26 |
| Sell* | 400 | 217.56p | Ordinary |
12:34:47 - 21-Apr-26 |
| Buy* | 10 | 223.00p | SI Trade |
08:10:24 - 21-Apr-26 |
| Sell* | 231 | 220.00p | Uncrossing Trade |
16:35:23 - 20-Apr-26 |
| Sell* | 3,222 | 219.077p | Ordinary |
15:25:51 - 20-Apr-26 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 9:30 am | RNS | 2025 Annual Report and Notice of AGM |
| 9th Apr 2026 7:00 am | RNS-R | Data to be Presented at AACR Annual Meeting 2026 |
| 23rd Mar 2026 7:00 am | RNS-R | HUTCHMED Initiates Phase III Trial of HMPL-760 |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 9th Mar 2026 9:30 am | RNS | Update on Licensed Oncology Product in China |
| 6th Mar 2026 8:30 am | RNS | Directorate change |
| 5th Mar 2026 1:00 pm | RNS-R | Publication of Form 20-F |